Hannover Medical School chip cytometry spinout Zelkraftwerk has been bought by Canopy Biosciences, providing an exit for tech transfer company Ascenion.

The Tencent-backed cosmetic procedure-booking and social media platform floated at the top of its range in a US offering that came after more than $229m of funding.

Pharmstandard, Lung Biotechnology and Posco celebrated exits as the organ transportation system developer went public in a $91m offering.

Exosome therapeutics developer Codiak BioSciences, exploiting technology developed by researchers at the universities of Gothenburg and Texas, is eyeing up to $86.3m in an IPO.

General Mills-backed meat substitute developer Beyond Meat priced its shares at the top of an expanded range, but Tyson Foods had already sold its stake.

Alexandria Real Estate Equities-backed exosome therapeutics developer Codiak BioSciences is eyeing up to $86.3m in a forthcoming IPO.

Telus Ventures is set to exit healthcare data management software producer Get Real Health in an $11m purchase by CPSI, six years after it invested.

Grove Collaborative has agreed to purchase the video commerce platform in a deal of undisclosed size that will allow CAA Ventures to exit.

Digital media company Cheddar has agreed to a purchase by investor Altice USA that will also provide exits for Antenna Group, Dentsu, Liberty Global, Comcast, Amazon, AT&T, NYSE and Broadway Video.

Alphabet, WuXi AppTec, Celgene, Roche and Novartis are in line to exit precision oncology therapy developer Ideaya Biosciences, which has filed to go public.